DEBORAH SUCHMAN: Open Payments
NPI 1972055457 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 18 payments from 7 companies in 2025. Trend: 2023 $137 · 2024 $225 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $134 |
| PFIZER INC. | 5 | $108 |
| Novo Nordisk Inc | 3 | $77 |
| Astellas Pharma US Inc | 3 | $75 |
| Lilly USA, LLC | 2 | $40 |
| Seqirus USA Inc | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $23 |
Products named: VOQUEZNA, Veozah, NURTEC ODT, Wegovy, Fluad, Ozempic, MOUNJARO, INSPIRE.
Industry payments across DC — which companies pay providers there.
